For November 2020, we have selected: Agarwal P. et al. Neurological manifestations in 404 COVID‑19 patients in Washington State. J Neurol 2020 Aug 6;1-3. doi: 10.1007/s00415-020-10087-z. Online ahead of print.
For November 2020, we have selected: Wang Z. et al. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol 2020;e203311. doi: 10.1001/jamaneurol.2020.3311. Online ahead of print.
Dementia with Lewy bodies (DLB) is a neurodegenerative disorder characterised by fluctuating cognition, recurrent visual hallucinations, impairment of sleep (REM sleep behaviour disorder) and parkinsonism.
Factors influencing long term outcomes after elective surgical intervention remain poorly studied. One recent study (Lamberink et al., 2020) addressed this issue analysing the association between histopathology and seizure outcome and drug freedom up to 5 years after epilepsy surgery.
Newest addition to Breaking News submitted by Neurooncology Panel: Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas
Newest contribution to Breaking News is by Dementia Panel: Tackling challenges in care of Alzheimer’s disease and other dementias amid the COVID-19 pandemic, now and in the future
Neurology residents and research fellows are profoundly contributing to the functioning of the healthcare system and academia. However, coping on a daily basis with the onerous requirement of residency programmes, long working hours and research activities could lead in some cases to professional dissatisfaction and have an impact on work-life balance with consequences on personal and workplace well-being, thus participating to an increased risk of burnout.